Ginkgo Biloba 40 mg

Get a Price/Quote

MOQ : 15-30 Boxes

Ginkgo Biloba 40 mg Specification

Drug Type
Specific Drug

Ingredients
Alprazolam 0.25 mg & Fluoxetine 20 mg

Physical Form
Tablets

Function
Other

Recommended For
Neurologic Sequelae associated with Alzehimers Diseases, Edema, Pre-mentrual syndrome, Tinnitus, Macular degeneration, Peripheral Vascular Diseases,Traumatic Brain Injury

Dosage
Adult: 40 mg TID, Max: 120-240 mg

Dosage Guidelines
Adult: 40 mg TID, Max: 120-240 mg

Suitable For
Adults, Aged Person

Ginkgo Biloba 40 mg Trade Information

Minimum Order Quantity
15-30 Boxes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Alu-Alu,10*10, Packing

Main Domestic Market
All India

Certifications
WHO-GMP

Ginkgo Biloba 40 mg About

Ginkgo Biloba 40 mg tablets are a specialized formulation designed to support adults and aged individuals in managing various health concerns. These tablets contain 40 mg of Ginkgo Biloba, a potent ingredient known for its therapeutic properties. Recommended for neurologic sequelae associated with Alzheimers disease, tinnitus, edema, premenstrual syndrome, macular degeneration, traumatic brain injury, and peripheral vascular diseases, this product aims to promote overall well-being. Dosage guidelines include taking 40 mg three times daily (TID), with a maximum daily dose of 120-240 mg, providing flexibility to cater to individual healthcare needs. The easy-to-access tablet form ensures convenience in usage and precise dosing. Crafted for export, manufacturing, and supply, Ginkgo Biloba 40 mg is ideal for those seeking high-quality, specific drug solutions for targeted health challenges.

FAQs of Ginkgo Biloba 40 mg:

Q: What is the recommended dosage for Ginkgo Biloba 40 mg tablets?

A: Adults are advised to take 40 mg three times daily (TID), with a maximum daily dose of 120-240 mg.

Q: What conditions is Ginkgo Biloba 40 mg recommended for?

A: It is recommended for Alzheimers-related neurological sequelae, tinnitus, edema, premenstrual syndrome, macular degeneration, traumatic brain injuries, and peripheral vascular diseases.